Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Purcell, Rachel V ^a   Visnovska, Martina ^b   Biggs, Patrick J ^c   Schmeier, Sebastian ^b   Frizelle, Frank A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MASSEY UNIVERSITY   (New Zealand)

^c MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; BIOLOGY; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTESTINE FLORA; MALE; METABOLISM; METAGENOME; METAGENOMICS; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METAGENOME; METAGENOMICS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RNA, RIBOSOMAL, 16S; TRANSCRIPTOME;

EID: 85029523309     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-11237-6     Document Type: Article

References (58)

1. Ferlay, J., et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359-386, doi: 10.1002/ijc.29210 (2015).
2. Jass, J. R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50, 113-130, doi: 10.1111/j.1365-2559.2006.02549.x (2007).
3. Leggett, B., Whitehall, V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138, 2088-2100, doi: 10.1053/j.gastro.2009.12.066 (2010).
4. Network, C. G. A. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337, doi: 10.1038/nature11252 (2012).
5. Domingo, E., et al. Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. J Pathol 229, 441-448, doi: 10.1002/path.4139 (2013).
6. Colussi, D., Brandi, G., Bazzoli, F., Ricciardiello, L. Molecular pathways involved in colorectal cancer: Implications for disease behavior and prevention. Int J Mol Sci 14, 16365-16385, doi: 10.3390/ijms140816365 (2013).
7. Kocarnik, J. M., Shiovitz, S., Phipps, A. I. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf) 3, 269-276, doi: 10.1093/gastro/gov046 (2015).
8. Guinney, J., et al. The consensus molecular subtypes of colorectal cancer. Nat Med 21, 1350-1356, doi: 10.1038/nm.3967 (2015).
9. Hooper, L. V., Gordon, J. I. Commensal host-bacterial relationships in the gut. Science 292, 1115-1118 (2001).
10. Gao, Z., Guo, B., Gao, R., Zhu, Q., Qin, H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol 6, 20, doi: 10.3389/fmicb.2015.00020 (2015).
11. Ahn, J., et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105, 1907-1911, doi: 10.1093/jnci/djt300 (2013).
12. Yu, J., et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut, doi: 10.1136/gutjnl-2015-309800 (2015).
13. Sobhani, I., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 6, e16393, doi: 10.1371/journal.pone.0016393 (2011).
14. Marchesi, J. R., et al. Towards the human colorectal cancer microbiome. PLoS One 6, e20447, doi: 10.1371/journal.pone.0020447 (2011).
15. Nakatsu, G., et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 6, 8727, doi: 10.1038/ncomms9727 (2015).
16. Michael, B. Burns., et al. Discrete mutations in colorectal cancer correlate with defined microbial communities in the tumor microenvironment. bioRxiv doi: 10.1101/090795 (2016).
17. Lennard, K. S., Goosen, R. W., Blackburn, J. M. Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development. PLoS One 11, e0166282, doi: 10.1371/journal.pone.0166282 (2016).
18. E., A. Comparison of sequencing utility programs. The Open Bioinformatics Journal 7, 1-8 (2013).
19. Cox, M. P., Peterson, D. A., Biggs, P. J. SolexaQA: At-a-glance quality assessment of Illumina second-generation sequencing data. BMC Bioinformatics 11, 485, doi: 10.1186/1471-2105-11-485 (2010).
20. Dobin, A., et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21, doi: 10.1093/bioinformatics/bts635 (2013).
21. Li, H., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079, doi: 10.1093/bioinformatics/btp352 (2009).
22. Anders, S., Pyl, P. T., Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166-169, doi: 10.1093/bioinformatics/btu638 (2015).
23. Love, M. I., Huber, W., Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol 15, 550, doi: 10.1186/s13059-014-0550-8 (2014).
24. Magoc, T., Salzberg, S. L. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963, doi: 10.1093/bioinformatics/btr507 (2011).
25. Caporaso, J. G., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336, doi: 10.1038/nmeth.f.303 (2010).
26. Wood, D. E., Salzberg, S. L. Kraken: Ultrafast metagenomic sequence classification using exact alignments. Genome Biol 15, R46, doi: 10.1186/gb-2014-15-3-r46 (2014).
27. Robinson, M. D., McCarthy, D. J., Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140, doi: 10.1093/bioinformatics/btp616 (2010).
28. Flanagan, L., et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 33, 1381-1390, doi: 10.1007/s10096-014-2081-3 (2014).
29. Purcell, R. V., Pearson, J., Frizelle, F. A., Keenan, J. I. Comparison of standard, quantitative and digital PCR in the detection of enterotoxigenic Bacteroides fragilis. Sci Rep 6, 34554, doi: 10.1038/srep34554 (2016).
30. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., Golani, I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125, 279-284 (2001).
31. Subramanian, A., et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102, 15545-15550, doi: 10.1073/pnas.0506580102 (2005).
32. Vogtmann, E., et al. Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One 11, e0155362, doi: 10.1371/journal.pone.0155362 (2016).
33. Li, H., et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet, doi: 10.1038/ng.3818 (2017).
34. Dunne, P. D., et al. Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer. Clin Cancer Res 22, 4095-4104, doi: 10.1158/1078-0432.CCR-16-0032 (2016).
35. Becht, E., et al. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy. Clin Cancer Res 22, 4057-4066, doi: 10.1158/1078-0432.CCR-15-2879 (2016).
36. Fessler, E., et al. TGFbeta signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype. EMBO Mol Med 8, 745-760, doi: 10.15252/emmm.201606184 (2016).
37. Fessler, E., et al. A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype. Oncogene 35, 6026-6037, doi: 10.1038/onc.2016.134 (2016).
38. Zackular, J. P., Rogers, M. A., Ruffin, M. T.t., Schloss, P. D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 7, 1112-1121, doi: 10.1158/1940-6207.CAPR-14-0129 (2014).
39. Mira-Pascual, L., et al. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 50, 167-179, doi: 10.1007/s00535-014-0963-x (2015).
40. Kostic, A. D., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22, 292-298, doi: 10.1101/gr.126573.111 (2012).
41. Castellarin, M., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22, 299-306, doi: 10.1101/gr.126516.111 (2012).
42. Burns, M. B., Lynch, J., Starr, T. K., Knights, D., Blekhman, R. Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment. Genome Med 7, 55, doi: 10.1186/s13073-015-0177-8 (2015).
43. Han, Y. W., et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 68, 3140-3146 (2000).
44. Kostic, A. D., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215, doi: 10.1016/j.chom.2013.07.007 (2013).
45. Rubinstein, M. R., et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206, doi: 10.1016/j.chom.2013.07.012 (2013).
46. Nosho, K., et al. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World J Gastroenterol 22, 557-566, doi: 10.3748/wjg.v22.i2.557 (2016).
47. Mehta, R. S., et al. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncol 3, 921-927, doi: 10.1001/jamaoncol.2016.6374 (2017).
48. Cho, E., et al. Fusobacterium hwasookii sp. nov., Isolated from a Human Periodontitis Lesion. Curr Microbiol 70, 169-175, doi: 10.1007/s00284-014-0692-7 (2015).
49. Mima, K., et al. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol 7, e200, doi: 10.1038/ctg.2016.53 (2016).
50. Binder Gallimidi, A., et al. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget 6, 22613-22623, doi: 10.18632/oncotarget.4209 (2015).
51. Wu, N., et al. Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb Ecol 66, 462-470, doi: 10.1007/s00248-013-0245-9 (2013).
52. Meuric, V., et al. Treponema denticola improves adhesive capacities of Porphyromonas gingivalis. Mol Oral Microbiol 28, 40-53, doi: 10.1111/omi.12004 (2013).
53. Grenier, D. Demonstration of a bimodal coaggregation reaction between Porphyromonas gingivalis and Treponema denticola. Oral Microbiol Immunol 7, 280-284 (1992).
54. Hajishengallis, G., Lamont, R. J. Dancing with the Stars: How Choreographed Bacterial Interactions Dictate Nososymbiocity and Give Rise to Keystone Pathogens, Accessory Pathogens, and Pathobionts. Trends Microbiol 24, 477-489, doi: 10.1016/j.tim.2016.02.010 (2016).
55. Orth, R. K., O'Brien-Simpson, N. M., Dashper, S. G., Reynolds, E. C. Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model. Mol Oral Microbiol 26, 229-240, doi: 10.1111/j.2041-1014.2011.00612.x (2011).
56. Dejea, C. M., et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci USA 111, 18321-18326, doi: 10.1073/pnas.1406199111 (2014).
57. Flynn, K. J., Baxter, N. T., Schloss, P. D. Metabolic and Community Synergy of Oral Bacteria in Colorectal Cancer. mSphere 1, doi: 10.1128/mSphere.00102-16 (2016).
58. Flemer, B., et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut, doi: 10.1136/gutjnl-2015-309595 (2016).